Dosage of Capecitabine and Cyclophosphamide Combination Therapy in Patients with Metastatic Breast Cancer

Background: Capecitabine is a highly effective and well-tolerated treatment for metastatic breast cancer (MBC) and extends survival when combined with docetaxel. Capecitabine and cyclophosphamide are orally administered and have preclinical synergy and non-overlapping toxicities. Patients and Method...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Anticancer research 2007-03, Vol.27 (2), p.1009-1013
Hauptverfasser:	OHNO, Shinji, MITSUYAMA, Shoshu, TAMURA, Kazuo, NISHIMURA, Reiki, TANAKA, Maki, HAMADA, Yuzo, KUROKI, Shoji
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Adult Aged Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - adverse effects Biological and medical sciences Breast Neoplasms - drug therapy Breast Neoplasms - pathology Capecitabine Cyclophosphamide - administration & dosage Cyclophosphamide - adverse effects Deoxycytidine - administration & dosage Deoxycytidine - adverse effects Deoxycytidine - analogs & derivatives Dose-Response Relationship, Drug Drug Administration Schedule Drug Synergism Fluorouracil - administration & dosage Fluorouracil - adverse effects Fluorouracil - analogs & derivatives Gynecology. Andrology. Obstetrics Humans Mammary gland diseases Medical sciences Middle Aged Neoplasm Metastasis Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!